Patients taking a GLP-1 for diabetes have a lower risk for AF at 3 years than those on other medications, report ...

Former FDA Commissioner Dr. David Kessler has just released an important new book on diet and wieght loss. He spoke to Forbes about the latest research and issues.

Demand has soared for treatments targeting the less alluring effects of getting skinny quick. Make your appointment, stat!

It was a ‘mutual agreement,’ Novo says in a statement. A search for Fruergaard Jørgensen’s successor is ongoing.

A federal jury in Delaware has awarded Regeneron (NASDAQ:REGN) more than $400M in damages after finding that Amgen ...

In the second part of his Pharma Commerce video interview, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, ...